NAT10 modulators for treating or preventing laminopathies, aging and cancer
US9809562B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 2, 2015 |
| Grant date | Nov 7, 2017 |
| Priority date | — |
| Expiry date | Apr 2, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer (such as a cancer characterized by low levels of LMNA expression).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.